Kluwer Competition Law Blog
Innovation Competition in EU Merger Control: The Commission in Pursuit of a New Greater Good?
January 23, 2018
The European Commission’s recent focus on the impact of mergers on innovation competition has sparked a heated debate amongst lawyers and economists. Innovation seems to have become the new “Greater Good” the Commission is pursuing when reviewing mergers, whether in the pharmaceutical or medical device sectors, in pesticides, engineering, ICT or other technology-driven industries.
This article was originally published on Kluwer Competition Law Blog.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026May Antitrust and Competition Bulletin: Top-of-Mind Global Antitrust IssuesMay 21, 2026Sidley Represents IMA Financial Group in Equity Recapitalization TransactionMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Represents Private Equity at Goldman Sachs Alternatives in the Acquisition of FGI WorldwideMay 12, 2026When “The Devil Made Me Do It” Is Not a Defense: Lessons in AI Governance and Organizational Oversight from an SDNY DecisionMay 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
